- Home
- ICLR vs UDR Comparison
ICLR vs UDR Comparison
Compare ICLR & UDR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICLR
- UDR
- Stock Information
- Founded
- ICLR 1990
- UDR 1972
- Country
- ICLR Ireland
- UDR United States
- Employees
- ICLR N/A
- UDR N/A
- Industry
- ICLR Biotechnology: Commercial Physical & Biological Resarch
- UDR Real Estate Investment Trusts
- Sector
- ICLR Health Care
- UDR Real Estate
- Exchange
- ICLR Nasdaq
- UDR Nasdaq
- Market Cap
- ICLR 16.4B
- UDR 13.6B
- IPO Year
- ICLR 1998
- UDR N/A
- Fundamental
- Price
- ICLR $201.39
- UDR $42.85
- Analyst Decision
- ICLR Strong Buy
- UDR Buy
- Analyst Count
- ICLR 12
- UDR 18
- Target Price
- ICLR $278.27
- UDR $44.72
- AVG Volume (30 Days)
- ICLR 913.3K
- UDR 1.8M
- Earning Date
- ICLR 02-19-2025
- UDR 02-05-2025
- Dividend Yield
- ICLR N/A
- UDR 3.98%
- EPS Growth
- ICLR 28.78
- UDR N/A
- EPS
- ICLR 9.53
- UDR 0.26
- Revenue
- ICLR $8,281,675,999.00
- UDR $1,700,177,000.00
- Revenue This Year
- ICLR $4.00
- UDR N/A
- Revenue Next Year
- ICLR $1.37
- UDR $6.08
- P/E Ratio
- ICLR $21.18
- UDR $165.91
- Revenue Growth
- ICLR 1.99
- UDR 2.15
- 52 Week Low
- ICLR $181.51
- UDR $34.76
- 52 Week High
- ICLR $347.72
- UDR $47.55
- Technical
- Relative Strength Index (RSI)
- ICLR 54.92
- UDR 54.78
- Support Level
- ICLR $181.51
- UDR $42.42
- Resistance Level
- ICLR $203.26
- UDR $43.13
- Average True Range (ATR)
- ICLR 6.32
- UDR 0.75
- MACD
- ICLR 1.50
- UDR 0.11
- Stochastic Oscillator
- ICLR 72.45
- UDR 67.65
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.
About UDR UDR Inc.
UDR Inc is a real estate investment trust that owns, operates, acquires, renovates, develops, redevelops, disposes of, and manages multifamily apartment communities in targeted markets located in the United States. The company has two reportable segments; Same-Store Communities segment represents those communities acquired, developed, and stabilized prior to January 1, 2021, and held as of December 31, 2022, and Non-Mature Communities/Other segment represents those communities that do not meet the criteria to be included in Same-Store Communities, including, but not limited to, recently acquired, developed and redeveloped communities, and the non-apartment components of mixed-use properties. It generates key revenue from Same-Store Communities.